Literature DB >> 32630780

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.

Ahmed Mostafa1, Ahmed Kandeil1, Mahmoud Shehata1, Rabeh El Shesheny1,2, Abdallah M Samy3, Ghazi Kayali4,5, Mohamed A Ali1.   

Abstract

Coronaviruses belong to a large family of viruses that can cause disease outbreaks ranging from the common cold to acute respiratory syndrome. Since 2003, three zoonotic members of this family evolved to cross species barriers infecting humans and resulting in relatively high case fatality rates (CFR). Compared to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV, CFR = 10%) and pandemic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, CFR = 6%), the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has scored the highest CFR (approximately 35%). In this review, we systematically summarize the current state of scientific knowledge about MERS-CoV, including virology and origin, epidemiology, zoonotic mode of transmission, and potential therapeutic or prophylactic intervention modalities.

Entities:  

Keywords:  MERS-CoV; coronavirus; epidemiology; zoonotic disease

Year:  2020        PMID: 32630780     DOI: 10.3390/microorganisms8070991

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  10 in total

1.  Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.

Authors:  Nariman Shahhosseini; George Giorgi Babuadze; Gary Wong; Gary P Kobinger
Journal:  Microorganisms       Date:  2021-04-26

Review 2.  Animal Coronaviruses and SARS-COV-2 in Animals, What Do We Actually Know?

Authors:  Paolo Bonilauri; Gianluca Rugna
Journal:  Life (Basel)       Date:  2021-02-05

3.  FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Ahmed Mostafa; Ahmed Kandeil; Yaseen A M M Elshaier; Omnia Kutkat; Yassmin Moatasim; Adel A Rashad; Mahmoud Shehata; Mokhtar R Gomaa; Noura Mahrous; Sara H Mahmoud; Mohamed GabAllah; Hisham Abbas; Ahmed El Taweel; Ahmed E Kayed; Mina Nabil Kamel; Mohamed El Sayes; Dina B Mahmoud; Rabeh El-Shesheny; Ghazi Kayali; Mohamed A Ali
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-04

4.  The adaptation of SARS-CoV-2 to humans.

Authors:  Eduardo Tosta
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-01-10       Impact factor: 2.743

Review 5.  COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines.

Authors:  Giuseppina Malcangi; Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Fabio Piras; Vito Settanni; Grazia Garofoli; Giulia Palmieri; Sabino Ceci; Assunta Patano; Antonio Mancini; Luigi Vimercati; Damiano Nemore; Arnaldo Scardapane; Biagio Rapone; Alexandra Semjonova; Maria Teresa D'Oria; Luigi Macchia; Ioana Roxana Bordea; Giovanni Migliore; Antonio Scarano; Felice Lorusso; Gianluca Martino Tartaglia; Delia Giovanniello; Ludovica Nucci; Nicola Maggialetti; Antonio Parisi; Marina Di Domenico; Nicola Brienza; Silvio Tafuri; Pasquale Stefanizzi; Luigi Curatoli; Alberto Corriero; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Children (Basel)       Date:  2022-02-12

6.  Calcium, Magnesium, and Zinc Supplementation during Pregnancy: The Additive Value of Micronutrients on Maternal Immune Response after SARS-CoV-2 Infection.

Authors:  Ioana Mihaela Citu; Cosmin Citu; Madalin-Marius Margan; Marius Craina; Radu Neamtu; Oana Maria Gorun; Bogdan Burlea; Felix Bratosin; Ovidiu Rosca; Mirela Loredana Grigoras; Andrei Motoc; Daniel Malita; Octavian Neagoe; Florin Gorun
Journal:  Nutrients       Date:  2022-03-30       Impact factor: 5.717

7.  Serosurvey for Middle East respiratory syndrome coronavirus antibody in dromedary camels and human patients at a secondary care hospital, Illela, Northwest Nigeria.

Authors:  Samson Polycarp Salam; Grace Sabo Nok Kia; Faleke Olufemi Oladayo; Iniobong Chukwuebuka Ikenna Ugochukwu
Journal:  Comp Clin Path       Date:  2022-04-28

8.  Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies.

Authors:  Omnia Kutkat; Yassmin Moatasim; Ahmed A Al-Karmalawy; Hamada S Abulkhair; Mokhtar R Gomaa; Ahmed N El-Taweel; Noura M Abo Shama; Mohamed GabAllah; Dina B Mahmoud; Ghazi Kayali; Mohamed A Ali; Ahmed Kandeil; Ahmed Mostafa
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

9.  Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies.

Authors:  Assem Barakat; Ahmed Mostafa; M Ali; Abdullah Mohammed Al-Majid; Luis R Domingo; Omnia Kutkat; Yassmin Moatasim; Komal Zia; Zaheer Ul-Haq; Yaseen A M M Elshaier
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

10.  EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.

Authors:  Wael H Roshdy; Helmy A Rashed; Ahmed Kandeil; Ahmed Mostafa; Yassmin Moatasim; Omnia Kutkat; Noura M Abo Shama; Mokhtar R Gomaa; Ibrahim H El-Sayed; Nancy M El Guindy; Amal Naguib; Ghazi Kayali; Mohamed A Ali
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.